Endocrine aspects of bromocriptine therapy in Parkinsonism
- PMID: 104006
- DOI: 10.1007/BF01579074
Endocrine aspects of bromocriptine therapy in Parkinsonism
Abstract
Plasma growth hormone (GH) concentrations in Parkinsonian patients following 3 months optimum therapy with bromocriptine showed no significant change from pretreatment values, whilst plasma prolactin concentrations were uniformly suppressed. Pretreatment GH and prolactin levels were unrelated to clinical disability, and no correlation between hormonal changes and therapeutic response was found. These results suggest the presence of different dopaminergic receptor mechanisms for GH and prolactin release as well as between the extrapyramidal and neuroendocrine systems.
Similar articles
-
Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine.J Neural Transm. 1978;42(2):151-7. doi: 10.1007/BF01675354. J Neural Transm. 1978. PMID: 650205
-
Bromocriptine suppression of TRH-stimulated prolactin and thyrotrophin release and accompanying inhibition of bromocriptine induced growth hormone release by TRH in normal man.Clin Endocrinol (Oxf). 1979 May;10(5):481-8. doi: 10.1111/j.1365-2265.1979.tb02104.x. Clin Endocrinol (Oxf). 1979. PMID: 113143 Clinical Trial.
-
Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients.Acta Neurol Scand. 1991 Mar;83(3):145-50. doi: 10.1111/j.1600-0404.1991.tb04666.x. Acta Neurol Scand. 1991. PMID: 1903236
-
Effect of bromocriptine on serum hormones in acromegaly.Horm Res. 1984;19(3):142-52. doi: 10.1159/000179881. Horm Res. 1984. PMID: 6425186
-
Drug therapy: Bromocriptine.N Engl J Med. 1979 Oct 18;301(16):873-8. doi: 10.1056/NEJM197910183011606. N Engl J Med. 1979. PMID: 384250 Review. No abstract available.
Cited by
-
Effect of low-dose bromocriptine in treatment of psychosis: the dopamine autoreceptor-stimulation strategy.Psychopharmacology (Berl). 1983;81(1):37-41. doi: 10.1007/BF00439271. Psychopharmacology (Berl). 1983. PMID: 6415730
-
Galactorrhoea after withdrawal of bromocriptine.Br Med J. 1980 Sep 13;281(6242):716. doi: 10.1136/bmj.281.6242.716. Br Med J. 1980. PMID: 7191752 Free PMC article. No abstract available.
-
Newer dopaminergic agents cause minimal endocrine effects in idiopathic Parkinson's disease.Clin Med Insights Endocrinol Diabetes. 2014 May 1;7:13-7. doi: 10.4137/CMED.S14902. eCollection 2014. Clin Med Insights Endocrinol Diabetes. 2014. PMID: 24855402 Free PMC article.
-
Effect of hypoglycaemia, TRH and levodopa on plasma growth hormone, prolactin, thyrotropin and cortisol in Parkinson's disease before and during therapy.J Neurol. 1986 Jun;233(3):149-52. doi: 10.1007/BF00314421. J Neurol. 1986. PMID: 3088217
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources